HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Centroblastic lymphoma of the thyroid supervening long-lasting chronic lymphocytic leukemia (B-CLL) demonstration of biclonality by immunohistochemical and gene rearrangement analysis.

Abstract
A 67-year-old woman suffering since 5 years from a so far nontreated B-CLL underwent hemithyroidectomy for a rapidly enlarging tumor. Histologically, the coincidence of a centroblastic lymphoma and thyroidal infiltration by the CLL was diagnosed. Immunohistology revealed typical immunoprofils for both, B-CLL and centroblastic lymphoma on the background of B cell differentiation antigens. The bitypical immunoglobulin light chain expression--lambda on the B-CLL cells and kappa on the centroblasts--suggested biclonality. This was confirmed by gene rearrangement analysis of peripheral leukemia cells and tumor tissue. Thus, the final diagnosis of a primary thyroidal lymphoma of the centroblastic type (stage IE) arising independently from a preexisting B-CLL was achieved. Consequently, the patient received local radiotherapy. In our opinion, the designation "Richter's Syndrome", readily applied in the literature, is inappropriate for this tumor constellation.
AuthorsL Trümper, D U Matthaei-Maurer, W Knauf, P Möller
JournalKlinische Wochenschrift (Klin Wochenschr) Vol. 66 Issue 16 Pg. 736-42 (Aug 15 1988) ISSN: 0023-2173 [Print] Germany
PMID3139912 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunoglobulin kappa-Chains
  • Immunoglobulin lambda-Chains
Topics
  • Aged
  • Female
  • Gene Rearrangement, B-Lymphocyte, Light Chain
  • Humans
  • Immunoenzyme Techniques
  • Immunoglobulin kappa-Chains (genetics)
  • Immunoglobulin lambda-Chains (genetics)
  • Leukemia, Lymphocytic, Chronic, B-Cell (genetics, pathology)
  • Lymphoma, Non-Hodgkin (genetics, pathology)
  • Neoplasms, Multiple Primary (genetics, pathology)
  • Thyroid Gland (pathology)
  • Thyroid Neoplasms (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: